Rehabilitating digoxinThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

This publication has 10 references indexed in Scilit:

• Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial
  European Heart Journal, 2005
• Relationship of Serum Digoxin Concentration to Mortality and Morbidity in Women in the Digitalis Investigation Group Trial
  Journal of the American College of Cardiology, 2005
• Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease
  New England Journal of Medicine, 2004
• Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
  The Lancet, 2003
• The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatment
  European Heart Journal, 2003
• Association of Serum Digoxin Concentration and Outcomes in Patients With Heart Failure
  JAMA, 2003
• Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart Failure
  New England Journal of Medicine, 2002
• The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure
  New England Journal of Medicine, 1997
• Rationale, design, implementation, and baseline characteristics of patients in the dig trial: A large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure
  Controlled Clinical Trials, 1996
• RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2
  Published by Elsevier ,1988